& Harrison, D
Most no-DAC human data is extrapolated from sermorelin trials (the non-substituted GHRH 1-29 fragment) and from combination protocols with GHRPs like ipamorelin or GHRP-6, where the Mod GRF contribution is difficult to isolate
Ozempic, Wegovy and Rybelsus Linked to Vomiting Risks In a study published in the medical journal, The BMJ , on January 29, 2024, researchers identified a significant link between the use of semaglutide-based drugs, such as Ozempic and Wegovy, and an elevated risk of adverse gastrointestinal side effects , including nausea, vomiting, and diarrhea
Similar results were observed in the STEP-HFpEF DM trial
In: Boullata J.I., Armenti V.T., editors
Phase 3 trials are ongoing and no version is approved for prescription use in the UK